David Rolfe (Trades, Portfolio) recently submitted the 13F filing for the second quarter of 2025, providing insights int ...

Zoetis’ second quarter saw revenue and adjusted earnings surpass Wall Street expectations, but the market responded ...

Animal health company Zoetis (NYSE:ZTS) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 4.2% year on year ...

From supporting identification of certain cell characteristics to complementing clinical expertise with remote pathologist ...

The reality is that people and animals will always need medicine, treatments, and other products to live long and comfortable ...

These two stocks come from completely different industries, but each could boost a long-term investor's returns.

Delve into the growing cat-focused biotech landscape. Cats are the second most adopted pets and biotech is making their lives ...

In a report released today, David Westenberg from Piper Sandler maintained a Buy rating on Zoetis, with a price target of $215.00. The company’s shares closed last Friday at $147.35. Take advantage of ...

There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the ...

Two cats who ingested the dog allergy medication experienced acute kidney injury and required 4 rounds of hemodialysis.

The global Veterinary Infectious Disease Diagnostics Market, valued at US$2.66 billion in 2024, stood at US$2.87 billion in ...

For the second year running, New Jersey's Merck tops the list of responsible companies, highlighting a strong commitment to sustainability and social responsibility among local firms.